Wilmington Trust’s AbbVie ABBV Stock Holding History

Wilmington Trust’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	$23.3M	Buy	413,536 +17,518	+4%	+$919K	0.39%	58
2014 Q1	$20.4M	Sell	396,018 -6,362	-2%	-$322K	0.35%	60
2013 Q4	$21.2M	Sell	402,380 -12,203	-3%	-$600K	0.36%	54
2013 Q3	$18.5M	Sell	414,583 -24,497	-6%	-$1.09M	0.32%	58
2013 Q2	$18.2M	Buy	+439,080	New	+$19.2M	0.36%	58

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wilmington Trust's ABBV Position: Q2 2014 in Review

Wilmington Trust increased its AbbVie (ABBV) stake by 4.4% in Q2 2014, buying an estimated $919K and bringing the position to 413,536 shares worth $23.3M. The position accounts for 0.39% of the portfolio, ranked #58.

Wilmington Trust first reported a position in ABBV in Q2 2013 and has held it in 5 quarters since. 1,457 funds tracked by Wall St. Rank hold ABBV as of Q2 2014.

Wilmington Trust held 413,536 shares of AbbVie worth $23.3M as of Q2 2014.
Wilmington Trust bought 17,518 AbbVie shares in Q2 2014, an estimated $919K.
AbbVie made up 0.39% of Wilmington Trust's portfolio in Q2 2014, its #58 holding.
Wilmington Trust first reported a position in AbbVie in Q2 2013 and has held it in 5 quarters since.
1,457 funds tracked by Wall St. Rank held AbbVie as of Q2 2014.

Based on Wilmington Trust's 13F filing for Q2 2014, filed 13 Aug 2014.